World's Best Scientists 2026 revealed!

D-Index & Metrics

Medicine

D-Index
126
Citations
49981
World Ranking
2991
National Ranking
1656

Overview

Robert S. Benjamin is affiliated with The University of Texas MD Anderson Cancer Center in the United States. Their work focuses predominantly within the field of Medicine, with particular contributions to subfields such as Pulmonary and Respiratory Medicine, Oncology, Cardiology and Cardiovascular Medicine, Pathology and Forensic Medicine, and Endocrinology, Diabetes and Metabolism.

Their research covers several main topics including:

  • Sarcoma Diagnosis and Treatment
  • Cardiac tumors and thrombi
  • Vascular Tumors and Angiosarcomas
  • Lymphoma Diagnosis and Treatment
  • Gastrointestinal Tumor Research and Treatment
  • CAR-T cell therapy research
  • Ear and Head Tumors

Robert S. Benjamin has contributed multiple papers to the scientific literature, including:

  • Adjuvant and Neoadjuvant Chemotherapy for Osteosarcoma: A Historical Perspective, 2020, published in Advances in Experimental Medicine and Biology
  • Immuno-genomic landscape of osteosarcoma, 2020, published in Nature Communications
  • Durvalumab plus tremelimumab in advanced or metastatic soft tissue and bone sarcomas: a single-centre phase 2 trial, 2022, published in The Lancet Oncology
  • Hypofractionated, 3-week, preoperative radiotherapy for patients with soft tissue sarcomas (HYPORT-STS): a single-centre, open-label, single-arm, phase 2 trial, 2022, published in The Lancet Oncology
  • Systemic therapies in advanced epithelioid haemangioendothelioma: A retrospective international case series from the World Sarcoma Network and a review of literature, 2021, published in Cancer Medicine

Their frequent co-authors include Neeta Somaiah, Anthony P. Conley, Vinod Ravi, Dejka M. Araujo, and Ravin Ratan, all of whom have co-published more than 20 papers with Robert S. Benjamin.

Regarding publication venues, Robert S. Benjamin has contributed significantly to:

  • Journal of Clinical Oncology
  • Cancers
  • Clinical Cancer Research
  • Cancer
  • The Lancet Oncology

Best Publications

  • Correlation of Computed Tomography and Positron Emission Tomography in Patients With Metastatic Gastrointestinal Stromal Tumor Treated at a Single Institution With Imatinib Mesylate: Proposal of New Computed Tomography Response Criteria

    Haesun Choi;Chuslip Charnsangavej;Silvana C. Faria;Homer A. Macapinlac

  • Phase III Randomized, Intergroup Trial Assessing Imatinib Mesylate At Two Dose Levels in Patients With Unresectable or Metastatic Gastrointestinal Stromal Tumors Expressing the Kit Receptor Tyrosine Kinase: S0033

    Charles D. Blanke;Cathryn Rankin;George D. Demetri;Christopher W. Ryan

  • Phase I Safety and Pharmacokinetic Study of Recombinant Human Anti-Vascular Endothelial Growth Factor in Patients With Advanced Cancer

    M. S. Gordon;K. Margolin;M. Talpaz;G. W. Sledge

  • NCCN Task Force report: management of patients with gastrointestinal stromal tumor (GIST)--update of the NCCN clinical practice guidelines.

    George D. Demetri;Robert S. Benjamin;Charles D. Blanke;Jean Yves Blay

  • Reduction of doxorubicin cardiotoxicity by prolonged continuous intravenous infusion.

    Sewa S. Legha;Robert S. Benjamin;Bruce Mackay;Michael Ewer

  • Consensus meeting for the management of gastrointestinal stromal tumors Report of the GIST Consensus Conference of 20–21 March 2004, under the auspices of ESMO

    Jean Yves Blay;Sylvie Bonvalot;Paolo Casali;Haesun Choi

  • Randomized phase II study of gemcitabine and docetaxel compared with gemcitabine alone in patients with metastatic soft tissue sarcomas

    Robert G. Maki;J. Kyle Wathen;Shreyaskumar R. Patel;Dennis A. Priebat

  • Correlation of kinase genotype and clinical outcome in the North American Intergroup Phase III Trial of imatinib mesylate for treatment of advanced gastrointestinal stromal tumor: CALGB 150105 Study by Cancer and Leukemia Group B and Southwest Oncology Group.

    Michael C. Heinrich;Kouros Owzar;Christopher L. Corless;Donna Hollis

  • Soft Tissue Sarcoma, Version 2.2016, NCCN Clinical Practice Guidelines in Oncology

    Margaret von Mehren;R. Lor Randall;Robert S. Benjamin;Sarah Boles

  • We Should Desist Using RECIST, at Least in GIST

    Robert S. Benjamin;Haesun Choi;Homer A. Macapinlac;Michael A. Burgess

  • Prognostic factors for patients with localized soft-tissue sarcoma treated with conservation surgery and radiation therapy: an analysis of 1225 patients.

    Gunar K. Zagars;Matthew T. Ballo;Peter W. T. Pisters;Raphael E. Pollock M.D.

  • CT evaluation of the response of gastrointestinal stromal tumors after imatinib mesylate treatment: a quantitative analysis correlated with FDG PET findings.

    Haesun Choi;Chuslip Charnsangavej;Silvana De Castro Faria;Eric P. Tamm

  • Adriamycin chemotherapy—efficacy, safety, and pharmacologic basis of an intermittent single high‐dosage schedule

    Robert S. Benjamin;Peter H. Wiernik;Nicholas R. Bachur

  • Sequential Biochemotherapy Versus Chemotherapy for Metastatic Melanoma: Results From a Phase III Randomized Trial

    Omar Eton;Sewa S. Legha;Agop Y. Bedikian;Jiun-Kae Jack Lee

  • Treatment of uveal melanoma metastatic to the liver. A review of the M.D. Anderson Cancer Center experience and prognostic factors

    AY Bedikian;SS Legha;G Mavligit;CH Carrasco

  • A Missense Mutation in KIT Kinase Domain 1 Correlates with Imatinib Resistance in Gastrointestinal Stromal Tumors

    Lei L. Chen;Jonathan C. Trent;Elsie F. Wu;Gregory N. Fuller

  • R1507, a Monoclonal Antibody to the Insulin-Like Growth Factor 1 Receptor, in Patients With Recurrent or Refractory Ewing Sarcoma Family of Tumors: Results of a Phase II Sarcoma Alliance for Research Through Collaboration Study

    Alberto S. Pappo;Shreyaskumar R. Patel;John Crowley;Denise K. Reinke

  • Outpatient treatment of febrile episodes in low-risk neutropenic patients with cancer

    Edward B. Rubenstein;Kenneth Rolston;Carmelita P Escalante;Ellen F Manzullo

  • An open-label, multicenter, phase II study of bevacizumab for the treatment of angiosarcoma and epithelioid hemangioendotheliomas

    M. Agulnik;J. L. Yarber;S. H. Okuno;M. von Mehren

  • Critical analysis of the current American Joint Committee on Cancer staging system for cutaneous melanoma and proposal of a new staging system.

    Antonio C. Buzaid;Merrick I. Ross;Charles M. Balch;Seng-jaw Soong

Frequent Co-Authors

Shreyaskumar Patel
Shreyaskumar Patel The University of Texas MD Anderson Cancer Center
Raphael E. Pollock
Raphael E. Pollock The Ohio State University
Alexander J. Lazar
Alexander J. Lazar The University of Texas MD Anderson Cancer Center
Barry W. Feig
Barry W. Feig The University of Texas MD Anderson Cancer Center
Peter W.T. Pisters
Peter W.T. Pisters The University of Texas MD Anderson Cancer Center
David S. Hong
David S. Hong The University of Texas MD Anderson Cancer Center
Sidney Wallace
Sidney Wallace The University of Texas MD Anderson Cancer Center
Gunar K. Zagars
Gunar K. Zagars The University of Texas MD Anderson Cancer Center
Robert G. Maki
Robert G. Maki University of Pennsylvania
Funda Meric-Bernstam
Funda Meric-Bernstam The University of Texas MD Anderson Cancer Center

If you think any of the details on this page are incorrect, let us know.

Report an issue

We appreciate your kind effort to assist us to improve this page, it would be helpful providing us with as much detail as possible in the text box below:

Related Online Degrees & Career Pathways

Pursuing a career in Medicine doesn’t always mean becoming a physician. There are diverse paths in healthcare that offer rewarding opportunities and can be accessed through flexible online programs.

For those interested in administrative roles, earning a healthcare administration degree online can open doors to leadership positions in hospitals, clinics, and other medical organizations. If working directly with medical records and insurance appeals to you, consider the best medical billing and coding schools online, many of which offer financial aid to help reduce costs.

Nursing continues to be in high demand, and different educational routes are available. Aspiring practical nurses may ask: do you have to take a teas test for lpn? Fortunately, some schools waive this requirement, making entry smoother. Already an RN with an associate’s degree? Numerous asn to fnp programs let you advance your career through convenient online bridge programs.

Exploring these related degrees can help you find a path that matches your interests, schedule, and goals in healthcare.

Best Scientists Citing Robert S. Benjamin

Trending Scientists

Recently Published Articles